Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11251695 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Efficacy of Pregabalin in Migraine Prevention
Condition: Migraine Disorders
Interventions: Drug: Pregabalin;   Drug: sodium valproate

Indicates status has not been verified in more than two years